This study will evaluate the safety, tolerability, and efficacy of valemetostat tosylate in combination with DXd ADC in patients with advanced solid tumors.
Advanced Solid Tumor
This study will evaluate the safety, tolerability, and efficacy of valemetostat tosylate in combination with DXd ADC in patients with advanced solid tumors.
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
-
City of Hope At Orange County Lennar Foundation Cancer Center, Irvine, California, United States, 92618
Valkyrie Clinical Trials, Los Angeles, California, United States, 90067
Sharp Memorial Hospital, San Diego, California, United States, 92123
Brcr Medical Center, Inc Dba Boca Raton Clinical Research, Plantation, Florida, United States, 33322
H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, United States, 33612
University of Hawaii At Manoa, Honolulu, Hawaii, United States, 96813
University of Chicago Medical Center, Chicago, Illinois, United States, 60637
Dana-Farber Cancer Institute - Parent., Boston, Massachusetts, United States, 02215
Memorial Sloan-Kettering Cancer Center (Mskcc) - New York, New York, New York, United States, 10065
Clinical Research Alliance, Westbury, New York, United States, 11590
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Daiichi Sankyo,
Global Clinical Leader, STUDY_DIRECTOR, Daiichi Sankyo
2028-11-01